Long-term outcomes of rituximab (RTX) therapy in recurrent Granulomatosis with Polyangiitis (GPA)
D. Gawryluk (Warsaw, Poland), J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland)
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: